The Yang-Tan WorkABILITY Incubator, recently launched through the ILR School’s Center for Applied Research on Work, will support innovative applied research projects and collaborations.
Targeting part of a key antiviral pathway may one day offer a new therapeutic approach to deterring or delaying cognitive decline, according to preclinical research led by Weill Cornell Medicine scientists.
The Cornell Center for Health Equity has launched its racial allyship training course, providing anyone who wants to learn to be a better ally with essential skills and tools they can use in their personal and professional lives.
Cornell’s Office of General Counsel, to engage proactively with groups across campuses, is planning a series of four workshops designed to educate Cornell community members on common legal challenges in higher education.
Dr. Robert A. Harrington, a cardiologist and chair of the Department of Medicine at Stanford University, has been named the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University.
A non-opioid designer molecule for treating chronic neuropathic pain has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute.
An interdisciplinary seminar in the fall semester took students from Ithaca to New York City to explore African American heritage sites and the people whose work keeps this history alive.
The National Institute on Aging of the National Institutes of Health has awarded a grant to Weill Cornell Medicine to develop a screening tool and intervention for elder neglect in patients with Alzheimer’s disease and related dementias.
Cancers often release molecules into the bloodstream that pathologically alter the liver, shifting it to an inflammatory state, causing fat buildup and impairing its normal detoxifying functions, according to a study from investigators at Weill Cornell Medicine.